No Data
No Data
Henan Lingrui Pharmaceutical Semi-Annual Report 2024
Summary of Henan Lingrui Pharmaceutical's Half-Year Report in 2024.
Wanhua Chemical Group: The net income in the first half of the year was 8.174 billion yuan, a year-on-year decrease of 4.6%; Tongyu Heavy Industry: Plans to spend 100 million to 200 million yuan to repurchase shares.
[Investment Projects] Xi'an Triangle Defense (300775.SZ): plan to establish joint venture company to build 1000MN/1250MN precision intelligent forging production line. GHT Co., Ltd. (300711.SZ): plan to invest in Xi'an industrial base project with the controlling shareholder and other related parties. GRG Metrology & Test Group (002967.SZ): plan to participate in the investment and construction of Guangzhou Data Group Xi'an Industrial base project with 338 million yuan. GRG Banking Equipment (002152.SZ): plan to participate in the investment and construction of Guangzhou Data Group Xi'an Industrial base project. [Contract Winning] Qingdao Hanhe Cable (002498.SZ): won the bid for approximately 0.577 billion yuan.
Henan Lingrui Pharmaceutical (600285.SH) released its first-half-year performance, with a net income of 413 million yuan, a year-on-year increase of 30.30%.
Henan Lingrui Pharmaceutical (600285.SH) released its 2024 interim report, during which the company achieved revenues of...
Little Excitement Around Henan Lingrui Pharmaceutical Co., Ltd.'s (SHSE:600285) Earnings
Retail Investors Who Have a Significant Stake Must Be Disappointed Along With Institutions After Henan Lingrui Pharmaceutical Co., Ltd.'s (SHSE:600285) Market Cap Dropped by CN¥694m
No Data